Pfizer Inc. buy Cantor Fitzgerald
Start price
18.05.23
/
50%
€34.10
Target price
18.05.24
-
Performance (%)
-22.43%
End price
19.05.24
€26.45
Summary
This prediction ended on 19.05.24 with a price of €26.45. The price of Pfizer Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.43%. Cantor_Fitzgerald has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Dividends of €1.92 are taken into consideration when calculating the performance. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | -0.751% | -0.751% | -26.304% |
| iShares Core DAX® | -0.552% | 3.281% | 15.052% |
| iShares Nasdaq 100 | -1.415% | 4.535% | 26.243% |
| iShares Nikkei 225® | -0.877% | -1.739% | 4.897% |
| iShares S&P 500 | -0.415% | 3.239% | 23.253% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten